{"": [80, 1274, 0], "Introduction": [1275, 4341, 0], "SARS-CoV-2 S protein receptor binding and membrane fusion": [4342, 7841, 0], "SARS-CoV-2-specific neutralizing monoclonal antibodies and their mechanisms of action": [7842, 10191, 0], "Antigenic view of SARS-CoV-2 NTD and nAb binding sites": [10273, 10914, 0], "Antigenic view of SARS-CoV-2 RBD and nAb binding sites": [10915, 12510, 0], "Binding ability of SARS-CoV-2 NTD-targeting nAbs": [13074, 14135, 0], "Neutralizing activity of SARS-CoV-2 NTD-targeting nAbs": [14136, 15280, 0], "Protective efficacy of SARS-CoV-2 NTD-targeting nAbs": [15281, 16429, 0], "Cross-reactivity and cross-neutralizing activity of SARS-CoV-2 NTD-targeting nAbs": [16430, 17346, 0], "Neutralizing antibodies targeting the NTD of SARS-CoV-2 S protein": [12511, 17346, 1], "Binding and cross-reactivity of SARS-CoV-2 RBD-targeting nAbs": [17926, 20755, 0], "Neutralizing and cross-neutralizing activity of SARS-CoV-2 RBD-targeting nAbs": [20756, 22439, 0], "Protective efficacy of SARS-CoV-2 RBD-targeting nAbs": [22440, 25602, 0], "Combination treatments with SARS-CoV-2 RBD-targeting nAbs": [25603, 27622, 0], "Neutralizing antibodies targeting the RBD of SARS-CoV-2 S protein": [17347, 27622, 1], "Neutralizing antibodies targeting other regions of the SARS-CoV-2 S protein": [27623, 29557, 0], "Neutralizing antibodies targeting other SARS-CoV-2 proteins": [29558, 30270, 0], "Multimeric neutralizing antibodies targeting multiple regions of SARS-CoV-2 proteins": [30271, 30937, 0], "Neutralizing antibodies to prevent and treat COVID-19 in humans": [30938, 35366, 0], "Potential challenges and improvement of SARS-CoV-2-specific nAbs": [35367, 42336, 0], "Antigenic view of the NTD and RBD of SARS-CoV-2 S protein and nAb binding sites": [10192, 42336, 1], "Conclusions and prospects": [42337, 43896, 0]}